Anteris Technologies Global (NASDAQ:AVR) Director Buys $102,190.00 in Stock

Posted by Francis Steltz on Jun 4th, 2026

Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report) Director Susan Elizabeth Knight purchased 11,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was bought at an average price of $9.29 per share, for a total transaction of $102,190.00. Following the transaction, the director directly owned 11,000 shares of the company’s stock, valued at $102,190. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link.

Anteris Technologies Global Trading Up 7.8%

Anteris Technologies Global stock traded up $0.70 during midday trading on Thursday, reaching $9.65. The company’s stock had a trading volume of 2,120,513 shares, compared to its average volume of 1,152,635. Anteris Technologies Global Corp. has a 52 week low of $2.85 and a 52 week high of $10.14. The business has a 50-day moving average price of $6.66 and a 200-day moving average price of $5.79. The stock has a market cap of $939.33 million, a PE ratio of -4.33 and a beta of 1.78.

Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last released its earnings results on Tuesday, May 12th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. The business had revenue of $0.49 million during the quarter, compared to the consensus estimate of $0.77 million. During the same quarter in the prior year, the firm earned ($0.61) EPS. As a group, research analysts predict that Anteris Technologies Global Corp. will post -1.14 EPS for the current fiscal year.

Institutional Trading of Anteris Technologies Global

A number of hedge funds have recently made changes to their positions in the company. L1 Capital Pty Ltd boosted its stake in shares of Anteris Technologies Global by 143.2% during the third quarter. L1 Capital Pty Ltd now owns 6,838,136 shares of the company’s stock valued at $30,772,000 after purchasing an additional 4,026,136 shares in the last quarter. ADAR1 Capital Management LLC boosted its stake in shares of Anteris Technologies Global by 205.9% during the first quarter. ADAR1 Capital Management LLC now owns 3,789,132 shares of the company’s stock valued at $21,030,000 after purchasing an additional 2,550,355 shares in the last quarter. Perceptive Advisors LLC boosted its stake in shares of Anteris Technologies Global by 104.4% during the first quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company’s stock valued at $19,011,000 after purchasing an additional 1,750,000 shares in the last quarter. Nantahala Capital Management LLC boosted its stake in shares of Anteris Technologies Global by 31.9% during the fourth quarter. Nantahala Capital Management LLC now owns 2,530,910 shares of the company’s stock valued at $12,629,000 after purchasing an additional 612,244 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in shares of Anteris Technologies Global by 32.7% during the third quarter. JPMorgan Chase & Co. now owns 1,417,627 shares of the company’s stock valued at $6,379,000 after purchasing an additional 349,299 shares in the last quarter.

Analysts Set New Price Targets

AVR has been the topic of a number of recent analyst reports. Barclays lifted their target price on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research report on Friday, May 15th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $15.00 target price on shares of Anteris Technologies Global in a research report on Friday, March 27th. Wells Fargo & Company initiated coverage on Anteris Technologies Global in a research report on Wednesday, March 11th. They issued an “overweight” rating and a $16.00 target price on the stock. Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Four research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $16.00.

Read Our Latest Stock Analysis on AVR

About Anteris Technologies Global

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.